Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Focusing on anti-dsDNA antibodies, the criteria stated a specification of ‘an abnormal anti-native DNA titer’ but they did not recommend any assay stringency or quality.”
From Anti-dsDNA antibodies in the classification criteria of systemic lupus erythematosus (2022) · cites this paper as [17]
In the citing paper
“The first classification criteria for SLE were formulated in 1971 by the American College of Rheumatology (ACR), followed by two revisions in 1982 and 1997.”
From Anti-dsDNA antibodies in the classification criteria of systemic lupus erythematosus (2022) · cites this paper as [17]
In the citing paper
“Both the 1971 and the revised 1982 criteria, further updated in 1997 by the ACR (formerly ARA) [17], required at least 4 of the 11 criteria for SLE classification to be present serially or simultaneously.”
From Anti-dsDNA antibodies in the classification criteria of systemic lupus erythematosus (2022) · cites this paper as [17]
In the citing paper
“For detection of anti-dsDNA antibodies only limited requirements for test characteristics were defined, varying from ‘increased titer’ [16,17], ‘above laboratory reference range (except for ELISA)’ [18], to ‘>90% specificity’ [19].”
From Anti-dsDNA antibodies in the classification criteria of systemic lupus erythematosus (2022) · cites this paper as [17]
In the citing paper
“SLE was diagnosed and classified based on either the revised American College of Rheumatology10 or the Systemic Lupus International Collaborating Clinics classification criteria.11”
From Evaluation of different ways to identify persistent positivity of lupus anticoagulant in systemic lupus erythematosus (2020) · cites this paper as [10]
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
Harris, E. N., Boey, M. L., Mackworth-Young, C. G., Gharavi, A. E., Patel, B. M., Loizou, S., & Hughes, G. R. V. (1983) · The Lancet · doi:10.1016/s0140-6736(83)91267-9 · Cited by 1,383
Brandt, J. T., Triplett, D. A., Alving, B. M., & Scharrer, I. (1995) · PubMed · Cited by 1,164
Brandt, J. T., Triplett, D. A., Alving, B., & Scharrer, I. (1995) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1649901 · Cited by 993
The “Primary” Antiphospholipid Syndrome: Major Clinical and Serological Features
ASHERSON, R. A., KHAMASHTA, M. A., ORDI-ROS, J., DERKSEN, R. H. W. M., MACHIN, S. J., BARQUINERO, J., OUTT, H. H., HARRIS, E. N., VILARDELL-TORRES, M., & HUGHES, G. R. V. (1989) · Medicine · doi:10.1097/00005792-198911000-00004 · Cited by 959
The "primary" antiphospholipid syndrome: major clinical and serological features.
Asherson, R. A., Khamashta, M. A., Ordi‐Ros, J., Derksen, R. H. W. M., Machin, S. J., Barquinero, J., OUTT, H. H., Harris, E. N., Vilardell, M., & Hughes, G. R. V. (1989) · PubMed · Cited by 892
Harris, E. N., Gharavi, A. E., Patel, S., & Hughes, G. R. (1987) · PubMed Central · Cited by 795
ALARCÓN-SEGOVIA, D., DELEZÉ, M., ORIA, C. V., SÁNCHEZ-GUERRERO, J., GÓMEZ-PACHECO, L., CABIEDES, J., FERNÁNDEZ, L., & DE LEÓN, S. P. (1989) · Medicine · doi:10.1097/00005792-198911000-00003 · Cited by 639
Harris, E. N. (1990) · American Journal of Clinical Pathology · doi:10.1093/ajcp/94.4.476 · Cited by 414
Exner, T., Triplett, D. A., Taberner, D. A., & Machin, S. J. (1991) · PubMed · Cited by 243
Cited by
Items 101–200 of 329
Kochi, Y., Yamada, R., Suzuki, A., Harley, J. B., Shirasawa, S., Sawada, T., Bae, S.-C., Tokuhiro, S., Chang, X., Sekine, A., et al. (2005) · Nature Genetics · doi:10.1038/ng1540 · Cited by 397
Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure
James, J. A., Neas, B. R., Moser, K. L., Hall, T., Bruner, G. R., Sestak, A. L., & Harley, J. B. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200105)44:5<1122::aid-anr193>3.0.co;2-d · Cited by 390
Lockshin, M. D., Kim, M., Laskin, C. A., Guerra, M., Branch, D. W., Merrill, J., Petri, M., Porter, T. F., Sammaritano, L., Stephenson, M. D., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34402 · Cited by 388
Predictors of major infections in systemic lupus erythematosus
Ruiz-Irastorza, G., Olivares, N., Ruiz-Arruza, I., Martinez-Berriotxoa, A., Egurbide, M.-V., & Aguirre, C. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2764 · Cited by 374
Gordon, C., Amissah-Arthur, M.-B., Gayed, M., Brown, S., Bruce, I. N., D’Cruz, D., Empson, B., Griffiths, B., Jayne, D., Khamashta, M., et al. (2018) · Rheumatology · doi:10.1093/rheumatology/kex286 · Cited by 365
Jakes, R. W., Bae, S., Louthrenoo, W., Mok, C., Navarra, S. V., & Kwon, N. (2012) · Arthritis Care & Research · doi:10.1002/acr.20683 · Cited by 364
Immunosuppressive Therapy in Connective Tissue Diseases-Associated Pulmonary Arterial Hypertension
Sanchez, O., Sitbon, O., Jaïs, X., Simonneau, G., & Humbert, M. (2006) · Chest · doi:10.1378/chest.130.1.182 · Cited by 363
Venken, K., Hellings, N., Thewissen, M., Somers, V., Hensen, K., Rummens, J., Medaer, R., Hupperts, R., & Stinissen, P. (2008) · Immunology · doi:10.1111/j.1365-2567.2007.02690.x · Cited by 360
Chang, A., Henderson, S. G., Brandt, D., Liu, N., Guttikonda, R., Hsieh, C., Kaverina, N., Utset, T. O., Meehan, S. M., Quigg, R. J., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1001983 · Cited by 360
Systemic Lupus Erythematosus in Children and Adolescents
Levy, D. M., & Kamphuis, S. (2012) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2012.03.007 · Cited by 359
Basophils and the T helper 2 environment can promote the development of lupus nephritis
Charles, N., Hardwick, D., Daugas, E., Illei, G. G., & Rivera, J. (2010) · Nature Medicine · doi:10.1038/nm.2159 · Cited by 359
The Incidence and Prevalence of Systemic Lupus Erythematosus, 2002–2004: The Georgia Lupus Registry
Lim, S. S., Bayakly, A. R., Helmick, C. G., Gordon, C., Easley, K. A., & Drenkard, C. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38239 · Cited by 359
Dai, Y., Huang, Y.-S., Tang, M., Lv, T.-Y., Hu, C.-X., Tan, Y.-H., Xu, Z.-M., & Yin, Y.-B. (2007) · Lupus · doi:10.1177/0961203307084158 · Cited by 356
Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study
Isenberg, D., Appel, G. B., Contreras, G., Dooley, M. A., Ginzler, E. M., Jayne, D., Sánchez-Guerrero, J., Wofsy, D., Yu, X., & Solomons, N. (2010) · Rheumatology · doi:10.1093/rheumatology/kep346 · Cited by 356
Gaffney, P. M., Kearns, G. M., Shark, K. B., Ortmann, W. A., Selby, S. A., Malmgren, M. L., Rohlf, K. E., Ockenden, T. C., Messner, R. P., King, R. A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14875 · Cited by 355
An international cohort study of cancer in systemic lupus erythematosus
Bernatsky, S., Boivin, J. F., Joseph, L., Rajan, R., Zoma, A., Manzi, S., Ginzler, E., Urowitz, M., Gladman, D., Fortin, P. R., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21029 · Cited by 353
Absher, D. M., Li, X., Waite, L. L., Gibson, A., Roberts, K., Edberg, J., Chatham, W. W., & Kimberly, R. P. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003678 · Cited by 351
Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus
Cappione, A., Anolik, J. H., Pugh-Bernard, A., Barnard, J., Dutcher, P., Silverman, G., & Sanz, I. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24179 · Cited by 350
Reproductive and menopausal factors and risk of systemic lupus erythematosus in women
Costenbader, K. H., Feskanich, D., Stampfer, M. J., & Karlson, E. W. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22510 · Cited by 349
Mariz, H. A., Sato, E. I., Barbosa, S. H., Rodrigues, S. H., Dellavance, A., & Andrade, L. E. C. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30084 · Cited by 347
Shen, N., Fu, Q., Deng, Y., Qian, X., Zhao, J., Kaufman, K. M., Wu, Y. L., Yu, C. Y., Tang, Y., Chen, J.-Y., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001337107 · Cited by 346
He, J., Zhang, R., Shao, M., Zhao, X., Miao, M., Chen, J., Liu, J., Zhang, X., Zhang, X., Jin, Y., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-215396 · Cited by 345
McElhone, K., Abbott, J., Shelmerdine, J., Bruce, I. N., Ahmad, Y., Gordon, C., Peers, K., Isenberg, D., Ferenkeh‐Koroma, A., Griffiths, B., et al. (2007) · Arthritis Care & Research · doi:10.1002/art.22881 · Cited by 341
Fukaya, S., Yasuda, S., Hashimoto, T., Oku, K., Kataoka, H., Horita, T., Atsumi, T., & Koike, T. (2008) · Rheumatology · doi:10.1093/rheumatology/ken342 · Cited by 337
Kalunian, K. C., Davis, J. C., Merrill, J. T., Totoritis, M. C., Wofsy, D., & for the IDEC‐131 Lupus Study Group (2002) · Arthritis & Rheumatism · doi:10.1002/art.10681 · Cited by 336
Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases
Perl, A. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.172 · Cited by 332
Dynamic landscape of immune cell-specific gene regulation in immune-mediated diseases
Ota, M., Nagafuchi, Y., Hatano, H., Ishigaki, K., Terao, C., Takeshima, Y., Yanaoka, H., Kobayashi, S., Okubo, M., Shirai, H., et al. (2021) · Cell · doi:10.1016/j.cell.2021.03.056 · Cited by 331
Griffiths, B., Mosca, M., & Gordon, C. (2005) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2005.03.010 · Cited by 328
Ruiz-Irastorza, G., Egurbide, M. V., Olivares, N., Martinez-Berriotxoa, A., & Aguirre, C. (2008) · Rheumatology · doi:10.1093/rheumatology/ken121 · Cited by 327
Wang, H., Li, T., Chen, S., Gu, Y., & Ye, S. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39296 · Cited by 325
Ordi-Ros, J., Sáez-Comet, L., Pérez-Conesa, M., Vidal, X., Riera-Mestre, A., Castro-Salomó, A., Cuquet-Pedragosa, J., Ortiz-Santamaria, V., Mauri-Plana, M., Solé, C., et al. (2019) · Annals of Internal Medicine · doi:10.7326/m19-0291 · Cited by 324
“Corresponding Author: Josefina Cortés-Hernández, MD, PhD, Department of Internal Medicine, Rheumatology Research Group, Vall d’Hebrón University Hospital Research Institute, Passeig Vall d’Hebrón 119-129, 08035, Barcelona, Spain; e-mail, fina.cortes@vhir.org.”
BackgroundPredicting outcomes of lupus nephritis with tubulointerstitial inflammation and scarring
Hsieh, C., Chang, A., Brandt, D., Guttikonda, R., Utset, T. O., & Clark, M. R. (2011) · Arthritis Care & Research · doi:10.1002/acr.20441 · Cited by 321
Antibody profiles for the diagnosis of antiphospholipid syndrome
Biasiolo, A., Pegoraro, C., Cucchini, U., Noventa, F., Iliceto, S., & Pengo, V. (2005) · Thrombosis and Haemostasis · doi:10.1160/th04-12-0839 · Cited by 320
Toloza, S. M. A., Uribe, A. G., McGwin, G., Alarcón, G. S., Fessler, B. J., Bastian, H. M., Vilá, L. M., Wu, R., Shoenfeld, Y., Roseman, J. M., et al. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20622 · Cited by 319
Chakravarty, E. F., Bush, T. M., Manzi, S., Clarke, A. E., & Ward, M. M. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22641 · Cited by 319
Hanly, J. G., Urowitz, M. B., Sanchez‐Guerrero, J., Bae, S. C., Gordon, C., Wallace, D. J., Isenberg, D., Alarcón, G. S., Clarke, A., Bernatsky, S., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22305 · Cited by 319
The prevalence and associations of fatigue in systemic lupus erythematosus
Tench, C. M. (2000) · Rheumatology · doi:10.1093/rheumatology/39.11.1249 · Cited by 317
The use of laboratory tests in the diagnosis of SLE
Egner, W. (2000) · Journal of Clinical Pathology · doi:10.1136/jcp.53.6.424 · Cited by 316
Alexander, T., Thiel, A., Rosen, O., Massenkeil, G., Sattler, A., Kohler, S., Mei, H., Radtke, H., Gromnica-Ihle, E., Burmester, G.-R., et al. (2009) · Blood · doi:10.1182/blood-2008-07-168286 · Cited by 316
Michel, M., Chanet, V., Dechartres, A., Morin, A.-S., Piette, J.-C., Cirasino, L., Emilia, G., Zaja, F., Ruggeri, M., Andrès, E., et al. (2009) · Blood · doi:10.1182/blood-2009-04-215368 · Cited by 316
Hanly, J. G., Urowitz, M. B., Su, L., Bae, S. C., Gordon, C., Wallace, D. J., Clarke, A., Bernatsky, S., Isenberg, D., Rahman, A., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.106351 · Cited by 311
Kuo, C.-F., Grainge, M. J., Valdes, A. M., See, L.-C., Luo, S.-F., Yu, K.-H., Zhang, W., & Doherty, M. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.3528 · Cited by 310
Kim, M.-H., Cho, Y.-S., Uhm, W.-S., Kim, S., & Bae, S.-C. (2005) · Quality of Life Research · doi:10.1007/s11136-004-5681-z · Cited by 309
Hervier, B., Devilliers, H., Stanciu, R., Meyer, A., Uzunhan, Y., Masseau, A., Dubucquoi, S., Hatron, P.-Y., Musset, L., Wallaert, B., et al. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.06.006 · Cited by 308
The Intrarenal Vascular Lesions Associated with Primary Antiphospholipid Syndrome
NOCHY, D., DAUGAS, E., DROZ, D., BEAUFILS, H., GRÜNFELD, J.-P., PIETTE, J.-C., BARIETY, J., & HILL, G. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v103507 · Cited by 307
Prevalence of mood and anxiety disorders in women with systemic lupus erythematosus
Bachen, E. A., Chesney, M. A., & Criswell, L. A. (2009) · Arthritis Care & Research · doi:10.1002/art.24519 · Cited by 306
Pons‐Estel, G. J., Alarcón, G. S., McGwin, G., Danila, M. I., Zhang, J., Bastian, H. M., Reveille, J. D., & Vilá, L. M. (2009) · Arthritis Care & Research · doi:10.1002/art.24538 · Cited by 306
Isenberg, D., Gordon, C., Licu, D., Copt, S., Rossi, C. P., Wofsy, D., Babini, A., Lazaro, M., Lucero, E., Merono, C., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-205067 · Cited by 306
Zhang, F., Bae, S.-C., Bass, D., Chu, M., Egginton, S., Gordon, D., Roth, D. A., Zheng, J., & Tanaka, Y. (2018) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2017-211631 · Cited by 305
Kato, Y., Park, J., Takamatsu, H., Konaka, H., Aoki, W., Aburaya, S., Ueda, M., Nishide, M., Koyama, S., Hayama, Y., et al. (2018) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2018-212988 · Cited by 304
The Role of Epigenetics in Autoimmune/Inflammatory Disease
Surace, A. E. A., & Hedrich, C. M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01525 · Cited by 302
Izmirly, P. M., Parton, H., Wang, L., McCune, W. J., Lim, S. S., Drenkard, C., Ferucci, E. D., Dall'Era, M., Gordon, C., Helmick, C. G., et al. (2021) · Arthritis & Rheumatology · doi:10.1002/art.41632 · Cited by 300
Genetic susceptibility to SLE: new insights from fine mapping and genome-wide association studies
Harley, I. T. W., Kaufman, K. M., Langefeld, C. D., Harley, J. B., & Kelly, J. A. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2571 · Cited by 297
Clinical aspects of autoimmune rheumatic diseases
Goldblatt, F., & O'Neill, S. G. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61499-3 · Cited by 297
PELAEZ-BALLESTAS, I., SANIN, L. H., MORENO-MONTOYA, J., ALVAREZ-NEMEGYEI, J., BURGOS-VARGAS, R., GARZA-ELIZONDO, M., RODRIGUEZ-AMADO, J., GOYCOCHEA-ROBLES, M.-V., MADARIAGA, M., ZAMUDIO, J., et al. (2011) · The Journal of Rheumatology Supplement · doi:10.3899/jrheum.100951 · Cited by 296
The Epidemiology of Antiphospholipid Syndrome: A Population‐Based Study
Duarte‐García, A., Pham, M. M., Crowson, C. S., Amin, S., Moder, K. G., Pruthi, R. K., Warrington, K. J., & Matteson, E. L. (2019) · Arthritis & Rheumatology · doi:10.1002/art.40901 · Cited by 296
Dall'Era, M., Chakravarty, E., Wallace, D., Genovese, M., Weisman, M., Kavanaugh, A., Kalunian, K., Dhar, P., Vincent, E., Pena‐Rossi, C., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.23047 · Cited by 294
Parodi, A., Davì, S., Pringe, A. B., Pistorio, A., Ruperto, N., Magni‐Manzoni, S., Miettunen, P., Bader‐Meunier, B., Espada, G., Sterba, G., et al. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24883 · Cited by 291
Macedo, A. C. L., & Isaac, L. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00055 · Cited by 290
Yao, Y., Richman, L., Higgs, B. W., Morehouse, C. A., de los Reyes, M., Brohawn, P., Zhang, J., White, B., Coyle, A. J., Kiener, P. A., et al. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24557 · Cited by 284
The role of B lymphocyte stimulator (BLyS) in systemic lupus erythematosus
Cancro, M. P., D’Cruz, D. P., & Khamashta, M. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38010 · Cited by 283
Cutaneous Lupus Erythematosus: Issues in Diagnosis and Treatment
Walling, H. W., & Sontheimer, R. D. (2009) · American Journal of Clinical Dermatology · doi:10.2165/11310780-000000000-00000 · Cited by 281
Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort
Namjou, B., Kothari, P. H., Kelly, J. A., Glenn, S. B., Ojwang, J. O., Adler, A., Alarcón-Riquelme, M. E., Gallant, C. J., Boackle, S. A., Criswell, L. A., et al. (2011) · Genes & Immunity · doi:10.1038/gene.2010.73 · Cited by 281
The EuroMyositis registry: an international collaborative tool to facilitate myositis research
Lilleker, J. B., Vencovsky, J., Wang, G., Wedderburn, L. R., Diederichsen, L. P., Schmidt, J., Oakley, P., Benveniste, O., Danieli, M. G., Danko, K., et al. (2018) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2017-211868 · Cited by 281
Clearance deficiency and systemic lupus erythematosus (SLE)
Gaipl, U. S., Munoz, L. E., Grossmayer, G., Lauber, K., Franz, S., Sarter, K., Voll, R. E., Winkler, T., Kuhn, A., Kalden, J., et al. (2007) · Journal of Autoimmunity · doi:10.1016/j.jaut.2007.02.005 · Cited by 277
Chakravarty, E. F., Colón, I., Langen, E. S., Nix, D. A., El-Sayed, Y. Y., Genovese, M. C., & Druzin, M. L. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2005.02.063 · Cited by 280
Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus
Adrianto, I., Wen, F., Templeton, A., Wiley, G., King, J. B., Lessard, C. J., Bates, J. S., Hu, Y., Kelly, J. A., Kaufman, K. M., et al. (2011) · Nature Genetics · doi:10.1038/ng.766 · Cited by 279
Erkan, D., Vega, J., Ramón, G., Kozora, E., & Lockshin, M. D. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37759 · Cited by 279
Antiphospholipid Syndrome Nephropathy in Systemic Lupus Erythematosus
Daugas, E., Nochy, D., Huong, D. L. T., Duhaut, P., Beaufils, H. A. A. G. A., Caudwell, V. A. A., Bariety, J., Piette, J.-C., & Hill, G. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v13142 · Cited by 279
Sarkar, M. K., Hile, G. A., Tsoi, L. C., Xing, X., Liu, J., Liang, Y., Berthier, C. C., Swindell, W. R., Patrick, M. T., Shao, S., et al. (2018) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2018-213197 · Cited by 279
Systemic Lupus Erythematosus: An Independent Risk Factor for Endothelial Dysfunction in Women
El-Magadmi, M., Bodill, H., Ahmad, Y., Durrington, P. N., Mackness, M., Walker, M., Bernstein, R. M., & Bruce, I. N. (2004) · Circulation · doi:10.1161/01.cir.0000136807.78534.50 · Cited by 276
Fernández, M., Alarcón, G. S., Calvo‐alén, J., Andrade, R., McGwin, G., Vilá, L. M., Reveille, J. D., & LUMINA Study Group (2007) · Arthritis Care & Research · doi:10.1002/art.22672 · Cited by 272
Somers, E. C., Marder, W., Christman, G. M., Ognenovski, V., & McCune, W. J. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21263 · Cited by 269
Guidelines for referral and management of systemic lupus erythematosus in adults
(1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199909)42:9<1785::aid-anr1>3.0.co;2-# · Cited by 269
Frangou, E., Chrysanthopoulou, A., Mitsios, A., Kambas, K., Arelaki, S., Angelidou, I., Arampatzioglou, A., Gakiopoulou, H., Bertsias, G. K., Verginis, P., et al. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2018-213181 · Cited by 269
Caielli, S., Veiga, D. T., Balasubramanian, P., Athale, S., Domic, B., Murat, E., Banchereau, R., Xu, Z., Chandra, M., Chung, C.-H., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0254-9 · Cited by 263
“…Society of Nephrology/Renal Pathology Society revised LN classification criteria and who on review of records fulfilled the American College of Rheumatology revised criteria for the classification of SLE 39,40 , were obtained from Pathologists Bio-Medical Laboratories (Lewisville, TX).”
Furie, R., Stohl, W., Ginzler, E. M., Becker, M., Mishra, N., Chatham, W., Merrill, J. T., Weinstein, A., McCune, W. J., Zhong, J., et al. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2506 · Cited by 263
Caforio, A. L. P., Adler, Y., Agostini, C., Allanore, Y., Anastasakis, A., Arad, M., Böhm, M., Charron, P., Elliott, P. M., Eriksson, U., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx321 · Cited by 263
Hak, A. E., Karlson, E. W., Feskanich, D., Stampfer, M. J., & Costenbader, K. H. (2009) · Arthritis Care & Research · doi:10.1002/art.24537 · Cited by 262
Mok, C. C., Kwok, R. C. L., & Yip, P. S. F. (2013) · Arthritis & Rheumatism · doi:10.1002/art.38006 · Cited by 261
Boddaert, J., Huong, D. L. T., Amoura, Z., Wechsler, B., Godeau, P., & Piette, J.-C. (2004) · Medicine · doi:10.1097/01.md.0000147737.57861.7c · Cited by 261
Weckerle, C. E., Franek, B. S., Kelly, J. A., Kumabe, M., Mikolaitis, R. A., Green, S. L., Utset, T. O., Jolly, M., James, J. A., Harley, J. B., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30187 · Cited by 259
Lapteva, L., Nowak, M., Yarboro, C. H., Takada, K., Roebuck‐Spencer, T., Weickert, T., Bleiberg, J., Rosenstein, D., Pao, M., Patronas, N., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22031 · Cited by 258
Ruiz-Irastorza, G., Khamashta, M. A., Castellino, G., & Hughes, G. R. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04239-2 · Cited by 257
Rituximab in severe, treatment-refractory interstitial lung disease
Keir, G. J., Maher, T. M., Ming, D., Abdullah, R., de Lauretis, A., Wickremasinghe, M., Nicholson, A. G., Hansell, D. M., Wells, A. U., & Renzoni, E. A. (2014) · Respirology · doi:10.1111/resp.12214 · Cited by 256
Bultink, I. E. M., Lems, W. F., Kostense, P. J., Dijkmans, B. A. C., & Voskuyl, A. E. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21110 · Cited by 253
KIR + CD8 + T cells suppress pathogenic T cells and are active in autoimmune diseases and COVID-19
Li, J., Zaslavsky, M., Su, Y., Guo, J., Sikora, M. J., van Unen, V., Christophersen, A., Chiou, S.-H., Chen, L., Li, J., et al. (2022) · Science · doi:10.1126/science.abi9591 · Cited by 249
Díaz-Lagares, C., Croca, S., Sangle, S., Vital, E. M., Catapano, F., Martínez-Berriotxoa, A., García-Hernández, F., Callejas-Rubio, J.-L., Rascón, J., D'Cruz, D., et al. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.10.009 · Cited by 246
Kaiser, R., Cleveland, C. M., & Criswell, L. A. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.093013 · Cited by 244
“SLE diagnosis was rigorously confirmed by medical record review according to the American College of Rheumatology (ACR) criteria.(8) 9 Baseline questionnaire data included demographic information, clinical characteristics and behavioural factors.”
MethodZhou, X.-J., Lu, X.-L., Lv, J.-C., Yang, H.-Z., Qin, L.-X., Zhao, M.-H., Su, Y., Li, Z.-G., & Zhang, H. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.140111 · Cited by 239
“A total of 1745 subjects, who were of Han ethnicity living in the north of China, was enrolled in the initial case–control study. The mean age of 807 SLE patients was 33.7±12.3 years and 89.1% were women. All SLE patients met American College of Rheumatology (ACR) classification according to the revised SLE criteria o…”
MethodInfluentialDemographic differences in the development of lupus nephritis: a retrospective analysis
Seligman, V. A., Lum, R. F., Olson, J. L., Li, H., & Criswell, L. A. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01118-x · Cited by 237
Xist ribonucleoproteins promote female sex-biased autoimmunity
Dou, D. R., Zhao, Y., Belk, J. A., Zhao, Y., Casey, K. M., Chen, D. C., Li, R., Yu, B., Srinivasan, S., Abe, B. T., et al. (2024) · Cell · doi:10.1016/j.cell.2023.12.037 · Cited by 233
Li, R., Sun, J., Ren, L.-M., Wang, H.-Y., Liu, W.-H., Zhang, X.-W., Chen, S., Mu, R., He, J., Zhao, Y., et al. (2012) · Rheumatology · doi:10.1093/rheumatology/ker370 · Cited by 232
Ritterhouse, L. L., Crowe, S. R., Niewold, T. B., Kamen, D. L., Macwana, S. R., Roberts, V. C., Dedeke, A. B., Harley, J. B., Scofield, R. H., Guthridge, J. M., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.148494 · Cited by 229
Lee, P. Y., Li, Y., Richards, H. B., Chan, F. S., Zhuang, H., Narain, S., Butfiloski, E. J., Sobel, E. S., Reeves, W. H., & Segal, M. S. (2007) · Arthritis & Rheumatism · doi:10.1002/art.23035 · Cited by 229
Merrill, J. T., van Vollenhoven, R. F., Buyon, J. P., Furie, R. A., Stohl, W., Morgan-Cox, M., Dickson, C., Anderson, P. W., Lee, C., Berclaz, P.-Y., et al. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-207654 · Cited by 223
Apotopes and the biliary specificity of primary biliary cirrhosis†
Lleo, A., Selmi, C., Invernizzi, P., Podda, M., Coppel, R. L., Mackay, I. R., Gores, G. J., Ansari, A. A., Van de Water, J., & Gershwin, M. E. (2009) · Hepatology · doi:10.1002/hep.22736 · Cited by 222
“The diagnosis of all cases was based on established criteria for PBC (16), SLE (17), AIH (18), PSC (19) and by detection of serum HCV-RNA for CHC by PCR.”
MethodInfluentialPerl, A. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12756 · Cited by 218
Vasculitis in Systemic Lupus Erythematosus: Prevalence and Clinical Characteristics in 670 Patients
Ramos-Casals, M., Nardi, N., Lagrutta, M., Brito-Zerón, P., Bové, A., Delgado, G., Cervera, R., Ingelmo, M., & Font, J. (2006) · Medicine · doi:10.1097/01.md.0000216817.35937.70 · Cited by 217
Smith, C. K., Vivekanandan‐Giri, A., Tang, C., Knight, J. S., Mathew, A., Padilla, R. L., Gillespie, B. W., Carmona‐Rivera, C., Liu, X., Subramanian, V., et al. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38703 · Cited by 216
Metadata
- Authors
- Hochberg, M. C.
- Affiliations
- American College of Rheumatology (US)
- Corresponding author
- Hochberg, Marc C.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 1997-09
- Volume
- 40
- Issue
- 9
- Pages
- 1725-1725
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2070527591
- Cited by
- 11,409
- References
- 13
- Citations by year
- 2026: 283 · 2025: 422 · 2024: 515 · 2023: 530 · 2022: 652 · 2021: 701 · 2020: 616 · 2019: 631 · 2018: 634 · 2017: 675 · 2016: 621 · 2015: 633 · 2014: 625 · 2013: 563 · 2012: 490
- FWCI
- 18.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Arthritis & Rheumatism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Health Sciences › Medicine › Rheumatology › Vasculitis and related conditions
- Keywords
- systemic lupus erythematosus, classification criteria, American College of Rheumatology, disease classification, lupus diagnosis
- MeSH terms
- Diagnosis, Differential, Humans, Lupus Erythematosus, Systemic, Rheumatology, Societies, Medical, United States, Antibodies, Antiphospholipid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.